Results 81 to 90 of about 36,146 (282)

Long‐term outcomes of nationwide coordinated neovascular AMD treatment: A study based on Polish national registry

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate long‐term outcomes of anti‐VEGF therapy for nAMD using the Polish Retinal Therapeutic Program Monitoring Registry. Methods The cohort consisted of 63 840 eyes with nAMD qualified for treatment from 2016 to 2022, with follow‐up through 31 October 2023. Long‐term follow‐up (>5 years) was conducted for 7631 eyes.
Sławomir Teper, Daniel Ledwoń, Adam Sendecki, Patrycja Romaniszyn‐Kania, Aleksandra Tuszy, Julia Nycz, Andrzej W. Mitas, Małgorzata Figurska, Edward Wylęgała, Marek Rękas   +9 more
wiley   +1 more source

Ranibizumab e bevacizumab intravítreo no tratamento da neovascularização de coróide extrafoveal da degeneração macular relacionada à idade [PDF]

, 2009
PURPOSE: To investigate the efficacy of vascular endothelial growth factor-specific (VEGF) monoclonal antibodies in the treatment of choroidal neovascularization secondary to age-related macular degeneration (AMD) that does not extend beneath the foveal ...
Amaro, Miguel Hage, Roller, Aaron Brock
core   +3 more sources

Systemic Blood Proteome Patterns Reflect Disease Phenotypes in Neovascular Age-Related Macular Degeneration [PDF]

, 2023
Steffen E. Künzel, Leonie T. M. Flesch, Dominik P. Frentzel, Vitus A. Knecht, Anne Rübsam, Felix Dreher, Moritz Schütte, Alexandre Dubrac, Bodo Lange, Marie‐Laure Yaspo, Hans Lehrach, Antonia M. Joussen, Oliver Zeitz   +12 more
openalex   +1 more source

Characterizing and assessing vision‐related quality of life among patients discontinued treatment for neovascular age‐related macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose This study characterized and assessed vision‐related quality of life (VRQoL) in patients with neovascular age‐related macular degeneration (nAMD) who discontinued treatment with intravitreal anti‐vascular endothelial growth factor (anti‐VEGF), comparing them to those undergoing treatment.
Noreddin Shekho, Anna Stage Vergmann, Frederik Nørregaard Pedersen, Lonny Stokholm, Benjamin Sommer Thinggaard   +4 more
wiley   +1 more source

Brolucizumab for Neovascular Age-Related Macular Degeneration (BEL Study)

Clinical Ophthalmology, 2023
Liesbeth Van Cleemput,1,2 Freya Peeters,1,2 Julie Jacob1,2 1Department of Ophthalmology, University Hospital Leuven, Leuven, Belgium; 2Research Group Ophthalmology, Department of Neurosciences, KU Leuven, Leuven, BelgiumCorrespondence: Liesbeth Van ...
Van Cleemput L, Peeters F, Jacob J
doaj  

Novel computer-based assessments of everyday visual function in people with age-related macular degeneration.

PLoS ONE, 2020
PurposeTo test the hypothesis that the performance in novel computer-based tasks of everyday visual function worsens with disease severity in people with non-neovascular age-related macular degeneration.MethodsParticipants with and without non ...
Bethany E Higgins, Deanna J Taylor, Wei Bi, Alison M Binns, David P Crabb   +4 more
doaj   +1 more source

Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF [PDF]

, 2010
Background Cumulative light exposure is significantly associated with progression of age-related macular degeneration (AMD). Inhibition of vascular endothelial growth factor is the main target of current antiangiogenic treatment strategies in AMD ...
Alge, C. S., Hirneiß, Christoph, Kampik, Anselm, Kernt, Marcus, Liegl, R. G., Neubauer, A. S., Ulbig, Michael W., Wolf, Armin   +7 more
core   +3 more sources

Deep Learning‐Based Detection of Reticular Pseudodrusen in Age‐Related Macular Degeneration

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Reticular pseudodrusen (RPD) signify a critical phenotype driving vision loss in age‐related macular degeneration (AMD). This study sought to develop and externally test a deep learning (DL) model to detect RPD on optical coherence tomography (OCT) scans with expert‐level performance.
Himeesh Kumar, Yelena Bagdasarova, Scott Song, Doron G. Hickey, Amy C. Cohn, Mali Okada, Robert P. Finger, Jan H. Terheyden, Ruth E. Hogg, Pierre‐Henry Gabrielle, Louis Arnould, Maxime Jannaud, Xavier Hadoux, Peter van Wijngaarden, Carla J. Abbott, Lauren A. B. Hodgson, Roy Schwartz, Adnan Tufail, Emily Y. Chew, Cecilia S. Lee, Erica L. Fletcher, Melanie Bahlo, Brendan R. E. Ansell, Alice Pébay, Robyn H. Guymer, Aaron Y. Lee, Zhichao Wu   +26 more
wiley   +1 more source

Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration [PDF]

, 2017
Background: It has been proposed that antioxidants may prevent cellular damage in the retina by reacting with free radicals that are produced in the process of light absorption.
Age-Related Eye Disease Study 2 Research Group, Age-Related Eye Disease Study Research Group, Age-Related Eye Disease Study Research Group, Akuffo, Akuffo, Andreatta, Angelo, Anonymous, Arnold, Bahrami, Barakat, Bartlett, Bartlett, Beatty, Beatty, Benzie, Berrow, Bjelakovic, Bonds, Bone, Broadhead, Bunce, Buschini, Cangemi, Carneiro, Chew, Chew, Chew, Chew, Chew, Chew, Christen, Christen, Christen, Christen, Clemons, Connolly, Cumurcu, Dawczynski, Dawczynski, Downie, Early Treatment Diabetic Retinopathy Study Research Group, Evans, Evans, Evans, Falsini, Franciose, Garrett, Garrett, Glanville, Goodrow, Grover, Hanus, Holz, Huang, Huang, Huang, Huang, Hubbard, Johnson, Kaiser, Kamburoglu, Khachik, Klein, Kolber, Kopsell, Kvansakul, Lai, Landrum, Lim, Liu, Lonn, Ma, Ma, Manikandan, Meagher, Moeller, Moriarty-Craige, Murray, Neelam, Newsome, Newsome, Nolan, Nolan, Nolan, Nussenblatt, Omenn, Owsley, Piermarocchi, Prasad, Richer, Richer, Richer, Richer, Robman, Rodriguez-Carmona, Rosenthal, Rudnicka, Sabour-Pickett, Sacconi, Sasamoto, Scalinci, Schalch, Schmetterer, Schmidl, Scorolli, Souied, Stur, Taylor, The, The Age-Related Eye Disease Study 2 (AREDS2) Research Group, The Age-Related Eye Disease Study Research Group, Tian, Tikellis, Told, Told, Trieschmann, Vannas, Wang, Wang, Weigert, Wenzel, Wolf-Schnurrbusch, Wong, Zampatti, Zeimer, Zhao   +126 more
core   +3 more sources

Ten‐Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age‐Related Macular Degeneration

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To evaluate the 10‐year cumulative incidence, progression rates, and risk factors for macular atrophy (MA) in neovascular age‐related macular degeneration (nAMD) patients receiving long‐term anti‐vascular endothelial growth factor (VEGF) therapy.
Francesco Romano, Marco Casaluci, Antonio Valastro, Matteo Airaldi, Paolo Milella, Francesco Pozzo Giuffrida, Elisa Cozzi, Andrea Aretti, Kelvin YC Teo, Chui Ming Gemmy Cheung, Marco Nassisi, Francesco Viola, Giovanni Staurenghi, Alessandro Invernizzi   +13 more
wiley   +1 more source